Ramakrishnan Arulraj, Velmurugan Ganesan, Somasundaram Aravindh, Mohanraj Sundaresan, Vasudevan Dinakaran, Vijayaragavan Paari, Nightingale Peter, Swaminathan Krishnan, Neuberger James
KMCH Research Foundation, Kovai Medical Center and Hospital, Coimbatore 641 014, Tamil Nadu, India.
Liver Unit, Kovai Medical Center and Hospital, Coimbatore 641 014, Tamil Nadu, India.
EClinicalMedicine. 2022 Jul 14;51:101553. doi: 10.1016/j.eclinm.2022.101553. eCollection 2022 Sep.
Liver disease is the only major chronic disease and mortality is increasing. Earlier detection of liver fibrosis can reduce progression to cirrhosis and hepatocellular carcinoma. Many studies have reported an increased prevalence in liver fibrosis among adults in urban regions but there are few data in physically active rural populations without attributable metabolic risk factors. This aim of this study is to investigate the prevalence of abnormal liver functions tests (LFTs) and liver fibrosis among adults in a rural population.
This cross-sectional study included observations from KMCH-NNCD-II (2017) study ( = 907) from a farming village, Nallampatti, located in South India. We assessed lifestyle (occupation, tobacco use and alcohol consumption using AUDIT-C questionnaire), markers for metabolic diseases (obesity, hypertension, diabetes, hypercholesterolemia), LFTs and markers for hepatitis viruses B and C. 901 participants had transient elastography to assess fibrosis. Participants with abnormal LFTs and significant liver fibrosis (F2-F4) underwent additional liver screening (caeruloplasmin, iron studies and autoimmune hepatitis panel). Multiple logistic regression analyses were performed to understand the association of liver fibrosis with lifestyle and metabolic risk factors after adjustment for co-variates.
Significant liver fibrosis (F2-F4) was observed in 14.4%, and cirrhosis in 0.8%. There was an association of liver fibrosis with abnormal LFTs but no association between alcohol consumption, viral hepatitis, hepatic liver screening and liver fibrosis. Among metabolic risk factors, no association was observed for hypertension and hypercholesterolemia but diabetes [OR - 3.206 (95% CI: 1.792 - 5.736)], obesity [1.987 (1.341 - 2.944)] and metabolic syndrome [2.539 (1.680 - 3.836)] showed association with significant liver fibrosis (F2-F4) after adjustment for confounding factors.
Our results suggest that the prevalence of liver fibrosis in rural population is similar to urban counterparts. The association of metabolic risk factors with liver fibrosis in physically active rural population warrants further investigations in future studies.
This study is funded by KMCH Research Foundation, India.
肝病是唯一主要的慢性疾病,且死亡率在上升。早期检测肝纤维化可减少肝硬化和肝细胞癌的进展。许多研究报告称城市地区成年人肝纤维化患病率增加,但对于没有可归因代谢风险因素的体力活动较多的农村人群,相关数据较少。本研究的目的是调查农村人群中成年人肝功能检查(LFTs)异常和肝纤维化的患病率。
这项横断面研究纳入了来自印度南部一个名为纳兰帕蒂的村庄的KMCH-NNCD-II(2017年)研究中的观察对象(n = 907)。我们评估了生活方式(职业、使用AUDIT-C问卷评估烟草使用和饮酒情况)、代谢性疾病标志物(肥胖、高血压、糖尿病、高胆固醇血症)、LFTs以及乙型和丙型肝炎病毒标志物。901名参与者接受了瞬时弹性成像以评估纤维化。LFTs异常且有显著肝纤维化(F2 - F4)的参与者接受了额外的肝脏筛查(铜蓝蛋白、铁代谢研究和自身免疫性肝炎检测项目)。在对协变量进行调整后,进行多因素逻辑回归分析以了解肝纤维化与生活方式和代谢风险因素之间的关联。
观察到显著肝纤维化(F2 - F4)的患病率为14.4%,肝硬化患病率为0.8%。肝纤维化与LFTs异常有关,但饮酒、病毒性肝炎、肝脏筛查与肝纤维化之间无关联。在代谢风险因素中,未观察到高血压和高胆固醇血症与肝纤维化有关联,但糖尿病[比值比 - 3.206(95%置信区间:1.792 - 5.736)]、肥胖[1.987(1.341 - 2.944)]和代谢综合征[2.539(1.680 - 3.836)]在对混杂因素进行调整后显示与显著肝纤维化(F2 - F4)有关联。
我们的结果表明农村人群肝纤维化患病率与城市人群相似。体力活动较多的农村人群中代谢风险因素与肝纤维化之间的关联值得未来研究进一步探讨。
本研究由印度KMCH研究基金会资助。